Health Professional Radio - Podcast

Dr. Mari Kurahashi, MD, MPH, Clinical Associate Professor, Psychiatry and Behavioral Sciences, Child and Adolescent Psychiatry at Stanford Children's Health discusses helping kids/teens cope with anxiety while returning back to school after a year of online learning, managing mask requirements, catching up on lessons, and reengaging w/friends (or making new friends) while staying safe. She offers...

Heidi Hinrichs, M.S., Divisional Vice President, Global Clinical and Regulatory Affairs, Abbott Cardiac Rhythm Management discusses finding her career path while studying biomedical engineering and learning how innovative medical technology can transform lives for the better. She rose through the ranks over 25 years from a clinical project leader to an executive, ensuring safety is first and forem...

Dr. Natalie Nunez Gomez, Head of Global Medical Affairs, Psoriasis at UCB, discusses new, interim long-term results from the bimekizumab BE BRIGHT open-label extension study presented at the European Academy of Dermatology and Venereology (EADV) Congress, as well as additional findings from the Phase 3/3b clinical program for bimekizumab in psoriasis.

Karen Zaderej, Chairman, CEO, and President at Axogen Inc. discusses the development and commercialization of technologies for peripheral nerve regeneration and repair that can restore nerve function and quality of life to patients using innovative, clinically proven, and economically effective solutions. This allows clinicians to repair damaged nerves more efficiently than current standard-of-car...

James Rolke, Director and CEO of Revelation Biosciences discusses how they are developing innate immune system therapeutics and diagnostics for the identification, prevention and treatment of respiratory viruses, including COVID-19. Their lead product candidate, REVTx-99 has the potential to broadly prevent or treat various respiratory infections including influenza, SARS-CoV-2, rhinovirus, RSV an...

Dr. Matthew Klein, MD, Chief Development Officer at PTC Therapeutics discusses Aromatic l-amino acid decarboxylase (AADC) deficiency, a very rare genetic disorder, and the results of a study published in "EMBO Molecular Medicine" from experts at leading children’s hospitals around the world, including Boston Children’s Hospital, that describes multiple clinical trials in which a novel gene therapy...

Dr. Christopher Gilmore, MD, of the Carolinas Pain Institute and lead author on the multi-center trial of the largest base of patients thus far evaluating SPR Therapeutics'​ ​​percutaneous ​peripheral ​nerve ​stimulation​ called SPRINT ® PNS for low back pain​ discusses this drug free, minimally invasive ​option​.​ ​​ The treatment is up to 60 days but offers long-term pain relief for many patient...

Hanan Ben-Asher, COO and Business Development at PixCell Medical discusses the development of a novel miniaturized portable hematology analyzer called HemoScreen™, which provides diagnostic results in minutes instead of days. With just one drop of blood and within six minutes, HemoScreen delivers accurate readings of 20 standard blood count parameters, saving patients, clinicians and health system...

Beth Wathen, American Association of Critical-Care Nurses (AACN) President and frontline nurse at Children's Hospital Colorado discusses AACN and what they are doing to make sure nurses' voices are heard. She talks about a recent survey on the Delta variant's impact on frontline nurses, and with ERs and ICUs flooded with COVID patients, how it impacts the rest of us. She shares the truth about lif...

Zimmer Biomet’s - ROSA® Hip System for Robotically-Assisted Direct Anterior Total Hip Surgery by Vertical Internet Media

New Methods in Prostate Cancer Detection by Vertical Internet Media

New Study - TREMFYA® Greater Efficacy vs. COSENTYX® by Vertical Internet Media

Happify Health - Ensemble - Prescription Digital Therapy by Vertical Internet Media

Accenture Health - 2021 Health and Life Sciences Experience Survey by Vertical Internet Media

SpringWorks Therapeutics - Desmoid Tumor Awareness by Vertical Internet Media

Proscia - Digital and Computational Pathology by Vertical Internet Media

Study Finds TREMFYA® Reduces Fatigue in PsA Patients by Vertical Internet Media

Rapid Innovation Needed in Hemodialysis Care by Vertical Internet Media

Dave Pierce, Executive VP and President, MedSurg and President, Endoscopy at Boston Scientific discusses the recent FDA clearance of its EXALT™ Model B Single-Use Bronchoscope, the latest device in the company’s single-use portfolio. Designed for use in bedside procedures within the intensive care unit (ICU) and operating room (OR), EXALT Model B provides an important option for the more than 1.2...

Dr. Ada Kumar, Medical Director in Medical Affairs at Horizon Therapeutics discusses recent findings from "Rheumatology" (July 10, 2021) which showed an "urgent need" for high-quality, prospective studies of patients hospitalized for gout flares. She talks about how clinicians can use the time a patient is hospitalized - when they are more receptive - to educate them on gout and how to treat it, w...

Dr. Richard Furie, Chief, Division of Rheumatology, Northwell Health, and principal investigator in​ the Saphnelo™ (anifrolumab) clinical trials for the treatment of moderate-to-severe systemic lupus erythematosus (SLE) discusses what this approval means for the SLE community. This complex disease hasn't seen a new treatment approved in over a decade. Saphnelo™ is also under regulatory review for...

Returning guest, Dr. William Haseltine, President, Access Health International, discusses his latest book "Science as a Superpower: My Lifelong Fight Against Disease and the Heroes who Made it Possible" (June 2021).

The COVID-19 pandemic has dramatically decreased blood donations, especially those for plasma. Thousands of patients rely on plasma-derived therapies to treat potentially deadly conditions like cancer, primary immunodeficiency disease, hemophilia, severe burns and more. One of these patients is John Boyle, who has lived with a rare primary immunodeficiency disease, X-linked agammaglobulinemia (XLA...

Mark Rothera, President and CEO of Silence Therapeutics discusses RNAi research and how the company is applying its mRNAi GOLD™ platform to precisely target and silence disease-associated genes in the liver, representing a substantial opportunity for both medicine and the company. He talks about redefining the approach to precision medicine, and the importance of treatment simplicity, to meet the...

​​Clinicians are acutely interested in delivering the best outcomes for their patients. One of the biggest challenges for healthcare providers is to get data that is reliable, accurate and timely. Dr. Rohit Uppal, MD, Chief Clinical Officer of TeamHealth Hospitalist Services, one of three groups that were compared in this IllumiCare study, discusses how Teamhealth is using IllumiCare’ s Smart Ribb...